Format

Send to

Choose Destination
Surg Oncol Clin N Am. 1998 Jul;7(3):471-85.

Genetically modified tumor cell vaccines.

Author information

1
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Abstract

Recent progress in identifying tumor antigens and understanding the host-tumor relationship have catalyzed a dramatic expansion of efforts to develop cancer vaccines. Gene transfer technologies have figured prominently in the design of many of these novel immunization schemes. This article highlights some of the key principles and controversies raised by experiments involving genetically modified tumor vaccines and speculates about future directions for investigators in this field.

PMID:
9624213
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center